Funder
the National Major and Technological Special Project for infectious disease during the Twelfth Five-year Plan Period
China Tuberculosis Clinical Trial Consortium(CTCTC) research funding
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. World Health Organization. Global tuberculosis report 2017. WHO/HTM/TB/2017.23. Geneva: World Health Organization. 2017. p. 21–63.
2. Kvasnovsky CL, Peter CJ, Van dWML. Treatment outcomes for patients with extensively drug-resistant tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa. Emerg Infect Dis. 2016;22(9):1529–36.
3. Liu CH, Li L, Chen Z, et al. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience. PLoS One. 2012;6(4):e19399.
4. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013;42(1):156–68.
5. Fan L, Sha W. Long - term prognosis of extensively drug-resistant TB (XDR-TB) in South Africa: a cohort study. Chin J Tuberc Res Dis. 2014;37(10):800.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献